Footnotes

• Contributors All authors should receive authorship credit based on the material contribution to this article, their revision of this article, and their final approval of this article for submission to this journal.

• Competing interests AMS: Penumbra Consulting, Honorarium, Speaker Bureau; Pulsar Vascular Consulting, Honorarium, Speaker Bureau; Microvention Consulting, Honorarium, Speaker Bureau, Research; Stryker Consulting, Honorarium, Speaker Bureau. AST: Codman Consulting, Honorarium, Speaker Bureau, Research Funding; Covidien Consulting, Honorarium, Speaker Bureau; Penumbra Consulting, Honorarium, Speaker Bureau, Research Grants; Microvention Consulting, Honorarium, Speaker Bureau, Research Grants; Blockade – Stock, Consulting, Honorarium, Speaker Bureau; Pulsar Vascular Stock, Consulting, Honorarium, Speaker Bureau, Research; Medtronic Consulting, Honorarium, Speaker Bureau. Minnetronix consulting Penumbra consulting Cerenovus consulting. ASA: Consultant for Johnson and Johnson, Leica, Medtronic, Microvention, Penumbra, Scientia, Siemens, Stryker; Research support from Microvention, Penumbra and Siemens; Shareholder Bendit, Cerebrotech, Endostream, Magneto, Neurogami, Serenity, Synchron and Triad Medical. D Fiorella: Medtronic (Consultant, Proctoring), Cerenovous (Royalties, Consulting), Microvention (Consulting, Research Support), Vascular Simulations (Board Member, Stockholder), Penumbra (Research Support), Siemens (Research Support), Neurogami (Stockholder). D Frei: Medical Advisory Board/Consultant/Speakers Bureau Ceranovus, Genentech, Penumbra, Shape Memory Medical, Stryker; Research support Ceranovus, Medtronic, Microvention, Penumbra, Siemens, Stryker; Stock ownership Penumbra.

• Patient consent Not required.

• Provenance and peer review Not commissioned; externally peer reviewed.

• Data sharing statement N/A.